These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 11989810

  • 1. Synthesis and antitumour activity of stereoisomers of 4-hydroperoxy derivatives of ifosfamide and its bromo analogue.
    Misiura K, Szymanowicz D, Kusnierczyk H, Wietrzyk J, Opolski A.
    Farmaco; 2002 Apr; 57(4):315-9. PubMed ID: 11989810
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and antitumor activity of analogues of ifosfamide modified in the N-(2-chloroethyl) group.
    Misiura K, Kinas RW, Stec WJ, Kusnierczyk H, Radzikowski C, Sonoda A.
    J Med Chem; 1988 Jan; 31(1):226-30. PubMed ID: 3336021
    [Abstract] [Full Text] [Related]

  • 3. Synthesis and antitumor activity of two ifosfamide analogs with a five-membered ring.
    Kutscher B, Niemeyer U, Engel J, Kleemann A, Hilgard P, Pohl J, Scheffler G.
    Arzneimittelforschung; 1995 Mar; 45(3):323-6. PubMed ID: 7741794
    [Abstract] [Full Text] [Related]

  • 4. Synthesis of 4-hydroperoxy derivatives of ifosfamide and trofosfamide by direct ozonation and preliminary antitumor evaluation in vivo.
    Hohorst HJ, Peter G, Struck RF.
    Cancer Res; 1976 Jul; 36(7 PT 1):2278-81. PubMed ID: 945124
    [Abstract] [Full Text] [Related]

  • 5. Anodic oxidation of ifosfamide and cyclophosphamide: a biomimetic metabolism model of the oxazaphosphorinane anticancer drugs.
    Paci A, Martens T, Royer J.
    Bioorg Med Chem Lett; 2001 May 21; 11(10):1347-9. PubMed ID: 11392552
    [Abstract] [Full Text] [Related]

  • 6. Synthesis, stereochemistry and antitumor activity of 4-hydroperoxyisophosphamide (NSC-227114) and related compounds.
    Takamizawa A, Matsumoto S, Iwata T, Makino I.
    Chem Pharm Bull (Tokyo); 1977 Aug 21; 25(8):1877-91. PubMed ID: 562722
    [No Abstract] [Full Text] [Related]

  • 7. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. II. Antiproliferative activity of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1986 Aug 21; 34(3):285-91. PubMed ID: 3592932
    [Abstract] [Full Text] [Related]

  • 8. Comparative studies on biological activity of /+/R and /-/S enantiomers of cyclophosphamide and ifosfamide. I. Antitumour effect of cyclophosphamide and ifosfamide enantiomers.
    Paprocka M, Kuśnierczyk H, Budzyński W, Rak J, Radzikowski C.
    Arch Immunol Ther Exp (Warsz); 1986 Aug 21; 34(3):275-84. PubMed ID: 3592931
    [Abstract] [Full Text] [Related]

  • 9. Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.
    Yazawa Y, Takagi T, Asakura S, Suzuki K, Kano Y.
    J Orthop Sci; 1999 Aug 21; 4(3):231-7. PubMed ID: 10370165
    [Abstract] [Full Text] [Related]

  • 10. In vitro studies on interaction of 4-hydroperoxyifosfamide and 2-mercaptoethanesulphonate in malignant gliomas.
    Jäger AH, Bogdahn U, Apfel R, Pfeufer B, Dekant A.
    J Cancer Res Clin Oncol; 1993 Aug 21; 119(12):721-6. PubMed ID: 8408185
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Synthesis and antitumor activity of preactivated isophosphamide analogues bearing modified alkylating functionalities.
    Takamizawa A, Matsumoto S, Iwata T, Makino I, Yamaguchi K, Uchida N, Kasai H, Shiratori O, Takase S.
    J Med Chem; 1978 Feb 21; 21(2):208-14. PubMed ID: 621716
    [Abstract] [Full Text] [Related]

  • 14. In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustard.
    Kutz ME, Mulkerin DL, Wiedemann GJ, Katschinski DM, Robins HI.
    Cancer Chemother Pharmacol; 1997 Feb 21; 40(2):167-71. PubMed ID: 9182839
    [Abstract] [Full Text] [Related]

  • 15. D-19575--a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport.
    Pohl J, Bertram B, Hilgard P, Nowrousian MR, Stüben J, Wiessler M.
    Cancer Chemother Pharmacol; 1995 Feb 21; 35(5):364-70. PubMed ID: 7850916
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological properties of racemic chlorobromofosfamide.
    Juszkiewicz M, Kleinrok Z, Sawiniec Z.
    Arch Immunol Ther Exp (Warsz); 1994 Feb 21; 42(5-6):405-13. PubMed ID: 8572900
    [Abstract] [Full Text] [Related]

  • 19. [Separation and pharmaco-toxicological studies of the enantiomers of Ifosfamide].
    Blaschke G, Hilgard P, Maibaum J, Niemeyer U, Pohl J.
    Arzneimittelforschung; 1986 Oct 21; 36(10):1493-5. PubMed ID: 3814210
    [Abstract] [Full Text] [Related]

  • 20. Synthesis, antitumor activity, and mechanism of action of benzo[b]chromeno[6,5-g][1,8]naphthyridin-7-one analogs of acronycine.
    Tian W, Yougnia R, Depauw S, Lansiaux A, David-Cordonnier MH, Pfeiffer B, Kraus-Berthier L, Léonce S, Pierré A, Dufat H, Michel S.
    J Med Chem; 2014 Dec 26; 57(24):10329-42. PubMed ID: 25360689
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.